Monosaccharides improve symptoms of an animal model for type III galactosemia, through the activation of the insulin pathway
Authors:
Open Access
- 16 November 2024
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 181, 117677
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (BFU2017/89780)
- Ministerio de Ciencia e Innovación (PID2020-120463RB-I00)
- Università degli Studi del Piemonte Orientale
- Federación Española de Enfermedades Raras (1380756)
This publication has 43 references indexed in Scilit:
- Molecular dynamics, residue network analysis, and cross-correlation matrix to characterize the deleterious missense mutations in GALE causing galactosemia IIICell Biochemistry and Biophysics, 2021
- Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular modelsJournal of Inherited Metabolic Disease, 2019
- Galactose Epimerase Deficiency: Expanding the Phenotype2017
- The metastability of human UDP-galactose 4′-epimerase (GALE) is increased by variants associated with type III galactosemia but decreased by substrate and cofactor bindingArchives of Biochemistry and Biophysics, 2014
- In silico prediction of the effects of mutations in the human UDP-galactose 4′-epimerase gene: Towards a predictive framework for type III galactosemiaGene, 2013
- Altered cofactor binding affects stability and activity of human UDP-galactose 4′-epimerase: Implications for type III galactosemiaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- In vivo and in vitro function of human UDP-galactose 4′-epimerase variantsBiochimie, 2011
- Analysis of UDP‐galactose 4′‐epimerase mutations associated with the intermediate form of type III galactosaemiaJournal of Inherited Metabolic Disease, 2008
- Galactose-1-phosphate in the pathophysiology of galactosemiaEuropean Journal of Pediatrics, 1995
- Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-GalUDP-GalNAc 4-epimerase deficient mutantCell, 1986